European Association for the Study of Diabetes

European Association for the Study of Diabetes
Name	European Association for the Study of Diabetes
Abbreviation	EASD
Formation	1965
Headquarters	Unknown
Region served	Europe
Membership	clinicians, researchers
Leader title	President

Contents

European Association for the Study of Diabetes is a professional association dedicated to research, clinical practice, and education related to diabetes mellitus and associated metabolic disorders. The association interacts with stakeholders from institutions such as World Health Organization, European Commission, National Institutes of Health, International Diabetes Federation, and academic centers including University of Oxford, Karolinska Institutet, and University of Cambridge. Its activities engage clinicians and researchers affiliated with hospitals like Charité – Universitätsmedizin Berlin, universities such as Imperial College London, and research institutes including Institut Pasteur, Max Planck Society, and Wellcome Trust-funded units.

History

The association was founded during the 1960s, in a period marked by meetings involving figures from Royal Society, European Molecular Biology Organization, and national societies such as the British Medical Association and Société Française de Diabétologie. Early conferences featured presenters from institutions including Harvard University, University of Vienna, University of Milan, and University of Barcelona. Over decades it developed links with organizations like European Medicines Agency, European Federation of Pharmaceutical Industries and Associations, and patient groups such as Diabetes UK and Juvenile Diabetes Research Foundation. Its timeline includes milestones contemporaneous with events at World Health Assembly, policy debates in the European Parliament, and advances reported at congresses in cities like Berlin, Paris, Madrid, and Rome.

The association’s mission emphasizes research translation and clinical excellence, aligning with priorities set by World Health Organization initiatives, research funding agencies such as European Research Council and Horizon Europe, and clinical guidelines from bodies like National Institute for Health and Care Excellence and American Diabetes Association. Objectives include fostering collaborations among centers such as Mayo Clinic, Cleveland Clinic, and Addenbrooke's Hospital; promoting basic science at laboratories including Cold Spring Harbor Laboratory and Salk Institute; and influencing policy dialogues in venues such as Council of Europe and European Council. It aims to bridge investigators from programs at Johns Hopkins University, Duke University, and Uppsala University with industry partners like Novo Nordisk, Sanofi, and AstraZeneca.

Governance is structured with elected officers including a President and committees reflecting practices seen in organizations like European Society of Cardiology and American Heart Association. Membership comprises clinical endocrinologists, basic scientists, and allied health professionals affiliated with institutions such as Mayo Clinic, Karolinska Institutet, University College London, and national societies including Swiss Society of Endocrinology and Diabetes. The association liaises with regulatory authorities like European Medicines Agency and collaborates with funding bodies such as Wellcome Trust and European Research Council. Committees work with representatives from universities like Trinity College Dublin and research centers like Helmholtz Association.

The association organizes annual scientific meetings modeled after congresses such as American Diabetes Association Scientific Sessions and collaborates with regional meetings held in locations like Vienna, Lisbon, and Athens. Sessions have featured work from investigators at Massachusetts General Hospital, Stanford University, ETH Zurich, and Technical University of Munich. Programs include symposia on topics paralleling sessions at European Congress of Endocrinology and workshops with partners such as International Diabetes Federation and European Chronic Disease Alliance. The meetings attract industry exhibits from companies like Roche, Bayer, and GlaxoSmithKline and involve poster presentations from trainees at institutions including University of Glasgow and KU Leuven.

The association supports peer-reviewed dissemination through journals and proceedings analogous to titles published by Springer Nature, Elsevier, and Oxford University Press. It curates content from multicenter trials conducted at sites like St Thomas' Hospital, Addenbrooke's Hospital, and Hospital Clínic de Barcelona, and publishes consensus statements in formats similar to those from American Diabetes Association and European Society of Cardiology. Editorial boards draw on experts from University of Copenhagen, University of Zurich, and Leiden University Medical Center. The association’s publications inform guideline committees at organizations such as NICE and influence reviews authored by contributors from Columbia University and Yale School of Medicine.

Educational programs include postgraduate courses, fellowships, and online modules comparable to offerings by European Union, WHO Regional Office for Europe, and academic providers like Karolinska Institutet and University of Oxford. Training initiatives partner with clinical sites such as Royal Free Hospital, Hôpital Pitié-Salpêtrière, and Bambino Gesù Hospital and with research networks funded by Horizon Europe and national research councils like Medical Research Council and Inserm. Awards recognize contributions by investigators affiliated with ETH Zurich, Imperial College London, and University of Edinburgh and are presented in ceremonies held alongside major congresses in cities such as Munich and Barcelona.

Category:Medical associations